Nanobe
Nanobacteria[edit]

Nanobacteria are a controversial topic in the field of microbiology and astrobiology. They are hypothesized to be the smallest form of life, with sizes ranging from 20 to 200 nanometers. The existence of nanobacteria has been debated since their discovery, with some researchers suggesting they are a new form of life, while others argue they are simply non-living mineral formations.
Discovery and Characteristics[edit]
Nanobacteria were first reported in the 1990s by Finnish researcher Olavi Kajander, who claimed to have isolated them from human and bovine blood. These entities were described as self-replicating and capable of forming calcium phosphate shells, similar to the mineral hydroxyapatite found in human bones and teeth.
Nanobacteria are purported to be resistant to extreme conditions, including high temperatures and radiation, which has led to speculation about their potential role in astrobiology and the possibility of life on other planets.
Controversy[edit]
The existence of nanobacteria is highly controversial. Critics argue that the structures identified as nanobacteria are too small to contain the necessary components for life, such as DNA and ribosomes. Some studies have suggested that these structures are actually mineral precipitates or artifacts of the methods used to observe them.
In 1996, NASA scientists reported finding nanobacteria-like structures in the ALH84001 meteorite, which originated from Mars. This finding sparked significant interest and debate about the possibility of life on Mars, although subsequent research has cast doubt on the biological nature of these structures.
Implications for Medicine[edit]
Some researchers have proposed that nanobacteria could play a role in human diseases, such as atherosclerosis, kidney stones, and Alzheimer's disease. The hypothesis is that nanobacteria could contribute to pathological calcification processes in the body. However, this remains a speculative area of research, and the medical community has not reached a consensus on the role of nanobacteria in disease.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian